GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Moderna's Vaccines Boss Leaves Company March 6, 2018 <b>eSight</b> 3 Launches In Europe June 22, 2017 What Happens to the FDA if the Government Shuts Down January 17, 2018
